SkyView Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-789
Closed -$278K 244
2026
Q1
$278K Sell
789
-446
-36% -$159K 0.04% 250
2025
Q4
$404K Sell
1,235
-196
-14% -$62.2K 0.05% 234
2025
Q3
$404K Hold
1,431
0.05% 232
2025
Q2
$397K Buy
1,431
+163
+13% +$46.2K 0.06% 219
2025
Q1
$395K Buy
+1,268
New +$374K 0.06% 216
2021
Q3
Sell
-1,024
Closed -$255K 369
2021
Q2
$255K Hold
1,024
0.12% 164
2021
Q1
$255K Sell
1,024
-149
-13% -$35.6K 0.11% 172
2020
Q4
$270K Buy
+1,173
New +$270K 0.13% 168

Other funds holding AMGN

SkyView Investment Advisors's AMGN Position: Q2 2026 in Review

SkyView Investment Advisors sold out of Amgen (AMGN) in Q2 2026, closing a stake of 789 shares — an estimated $278K sold.

SkyView Investment Advisors first reported a position in AMGN in Q4 2020 and held it in 8 quarters. The position peaked at $404K in Q4 2025. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • SkyView Investment Advisors reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • SkyView Investment Advisors sold 789 Amgen shares in Q2 2026, an estimated $278K.
  • SkyView Investment Advisors first reported a position in Amgen in Q4 2020 and held it in 8 quarters.
  • SkyView Investment Advisors's Amgen position peaked at $404K in Q4 2025.
  • 3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on SkyView Investment Advisors's 13F filing for Q2 2026, filed 15 Sep 2026.